CompuMed, Inc. (CMPD)
USD 3.23
(0.0%)
USD 3.23
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 690.19 Thousand USD | -42.17% |
| 2022 | 1.11 Million USD | -18.11% |
| 2021 | 1.48 Million USD | 117.02% |
| 2020 | 629.45 Thousand USD | -50.34% |
| 2019 | 1.26 Million USD | 217.33% |
| 2018 | 399.43 Thousand USD | 140.16% |
| 2017 | 166.31 Thousand USD | 37.84% |
| 2016 | 128.01 Thousand USD | 0.0% |
| 2011 | -196 Thousand USD | -34.53% |
| 2010 | -223 Thousand USD | -364.58% |
| 2009 | -50 Thousand USD | 95.89% |
| 2008 | -1.23 Million USD | -83.65% |
| 2007 | -991 Thousand USD | -69.6% |
| 2006 | -375 Thousand USD | -22.15% |
| 2005 | -281 Thousand USD | -28.45% |
| 2004 | -176 Thousand USD | -24.48% |
| 2003 | -170 Thousand USD | 52.0% |
| 2002 | -326 Thousand USD | 31.39% |
| 2001 | -590 Thousand USD | 55.22% |
| 2000 | -1.29 Million USD | -44.67% |
| 1999 | -900 Thousand USD | 47.06% |
| 1998 | -1.3 Million USD | 10.53% |
| 1997 | -2 Million USD | -235.71% |
| 1996 | -1.8 Million USD | 180.0% |
| 1995 | -1 Million USD | 400.0% |
| 1994 | -1.6 Million USD | 105.88% |
| 1993 | -1.7 Million USD | 15.0% |
| 1992 | -1.7 Million USD | -150.0% |
| 1991 | -500 Thousand USD | 16.67% |
| 1990 | -600 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 183.7 Thousand USD | 24.22% |
| 2024 Q3 | 278.44 Thousand USD | 9.69% |
| 2024 Q2 | 254.46 Thousand USD | 36.05% |
| 2023 Q2 | 146.47 Thousand USD | -12.76% |
| 2023 FY | - USD | -42.17% |
| 2023 Q4 | 146.48 Thousand USD | -21.3% |
| 2023 Q3 | 186.13 Thousand USD | 27.08% |
| 2023 Q1 | 167.9 Thousand USD | -60.31% |
| 2022 Q4 | 423.07 Thousand USD | 51.48% |
| 2022 Q2 | 194 Thousand USD | -12.75% |
| 2022 Q1 | 222.35 Thousand USD | -62.75% |
| 2022 Q3 | 279.3 Thousand USD | 43.97% |
| 2022 FY | - USD | -18.11% |
| 2021 Q3 | 337.81 Thousand USD | 39.15% |
| 2021 Q4 | 596.88 Thousand USD | 76.69% |
| 2021 FY | - USD | 117.02% |
| 2021 Q2 | 242.77 Thousand USD | 0.0% |
| 2020 FY | - USD | -50.34% |
| 2019 FY | - USD | 217.33% |
| 2018 FY | - USD | 140.16% |
| 2017 FY | - USD | 37.84% |
| 2016 FY | - USD | 0.0% |
| 2011 Q4 | -46 Thousand USD | -2.22% |
| 2011 FY | - USD | -34.53% |
| 2011 Q3 | -45 Thousand USD | 48.86% |
| 2011 Q1 | -119 Thousand USD | -296.67% |
| 2011 Q2 | -88 Thousand USD | 26.05% |
| 2010 FY | - USD | -364.58% |
| 2010 Q1 | -109 Thousand USD | -678.57% |
| 2010 Q2 | -31 Thousand USD | 71.56% |
| 2010 Q3 | -53 Thousand USD | -70.97% |
| 2010 Q4 | -30 Thousand USD | 43.4% |
| 2009 Q2 | 50 Thousand USD | 158.82% |
| 2009 FY | - USD | 95.89% |
| 2009 Q3 | -9000.00 USD | -118.0% |
| 2009 Q4 | -14 Thousand USD | -55.56% |
| 2009 Q1 | -85 Thousand USD | 55.26% |
| 2008 FY | - USD | -83.65% |
| 2008 Q4 | -190 Thousand USD | -79.25% |
| 2008 Q3 | -106 Thousand USD | 80.41% |
| 2008 Q2 | -541 Thousand USD | -63.94% |
| 2008 Q1 | -330 Thousand USD | -32.0% |
| 2007 Q2 | -73 Thousand USD | 58.99% |
| 2007 FY | - USD | -69.6% |
| 2007 Q4 | -250 Thousand USD | -113.68% |
| 2007 Q3 | -117 Thousand USD | -60.27% |
| 2007 Q1 | -178 Thousand USD | -33.83% |
| 2006 Q1 | -15 Thousand USD | 90.38% |
| 2006 Q3 | -114 Thousand USD | -40.74% |
| 2006 FY | - USD | -22.15% |
| 2006 Q4 | -133 Thousand USD | -16.67% |
| 2006 Q2 | -81 Thousand USD | -440.0% |
| 2005 Q3 | -43 Thousand USD | -258.33% |
| 2005 FY | - USD | -28.45% |
| 2005 Q4 | -156 Thousand USD | -262.79% |
| 2005 Q1 | -95 Thousand USD | 1.04% |
| 2005 Q2 | -12 Thousand USD | 87.37% |
| 2004 Q2 | -96 Thousand USD | -1700.0% |
| 2004 Q4 | -96 Thousand USD | -77.78% |
| 2004 Q3 | -54 Thousand USD | 43.75% |
| 2004 Q1 | 6000.00 USD | 110.34% |
| 2004 FY | - USD | -24.48% |
| 2003 Q4 | -58 Thousand USD | -1833.33% |
| 2003 FY | - USD | 52.0% |
| 2003 Q2 | -7000.00 USD | 85.58% |
| 2003 Q1 | -102 Thousand USD | -19.54% |
| 2003 Q3 | -3000.00 USD | 80.0% |
| 2002 FY | - USD | 31.39% |
| 2002 Q3 | -228 Thousand USD | -942.86% |
| 2002 Q4 | -4000.00 USD | 60.27% |
| 2002 Q1 | -73 Thousand USD | 1.35% |
| 2002 Q2 | -21 Thousand USD | 71.23% |
| 2001 FY | - USD | 55.22% |
| 2001 Q4 | -74 Thousand USD | -164.29% |
| 2001 Q3 | -37 Thousand USD | 82.93% |
| 2001 Q2 | -163 Thousand USD | 48.26% |
| 2001 Q1 | -316 Thousand USD | 22.49% |
| 2000 Q3 | -393 Thousand USD | -70.04% |
| 2000 FY | - USD | -44.67% |
| 2000 Q2 | -216 Thousand USD | -33.5% |
| 2000 Q4 | -543 Thousand USD | 9.91% |
| 2000 Q1 | -221 Thousand USD | 0.0% |
| 1999 Q2 | -200 Thousand USD | 33.33% |
| 1999 FY | - USD | 47.06% |
| 1999 Q4 | -200 Thousand USD | -100.0% |
| 1999 Q3 | -100 Thousand USD | 50.0% |
| 1999 Q1 | -300 Thousand USD | 50.0% |
| 1998 Q1 | -500 Thousand USD | 0.0% |
| 1998 FY | - USD | 10.53% |
| 1998 Q4 | -400 Thousand USD | -100.0% |
| 1998 Q3 | -300 Thousand USD | 0.0% |
| 1998 Q2 | -300 Thousand USD | 40.0% |
| 1997 Q4 | -500 Thousand USD | -25.0% |
| 1997 Q3 | -400 Thousand USD | 42.86% |
| 1997 Q2 | -600 Thousand USD | -75.0% |
| 1997 Q1 | -400 Thousand USD | -33.33% |
| 1997 FY | - USD | -235.71% |
| 1996 Q2 | -600 Thousand USD | -16.67% |
| 1996 FY | - USD | 180.0% |
| 1996 Q1 | -500 Thousand USD | -20.0% |
| 1996 Q4 | -300 Thousand USD | -112.0% |
| 1996 Q3 | -200 Thousand USD | 457.14% |
| 1995 Q1 | 800 Thousand USD | 500.0% |
| 1995 FY | - USD | 400.0% |
| 1995 Q3 | -200 Thousand USD | 50.0% |
| 1995 Q4 | -500 Thousand USD | -400.0% |
| 1995 Q2 | -200 Thousand USD | -125.0% |
| 1994 Q3 | -400 Thousand USD | -137.5% |
| 1994 Q4 | -200 Thousand USD | 33.33% |
| 1994 Q2 | 800 Thousand USD | 500.0% |
| 1994 Q1 | -200 Thousand USD | 50.0% |
| 1994 FY | - USD | 105.88% |
| 1993 Q3 | -300 Thousand USD | -130.0% |
| 1993 Q4 | -400 Thousand USD | -33.33% |
| 1993 FY | - USD | 15.0% |
| 1993 Q2 | 1 Million USD | 42.86% |
| 1993 Q1 | 700 Thousand USD | 114.0% |
| 1992 Q1 | 1 Million USD | 125.0% |
| 1992 FY | - USD | -150.0% |
| 1992 Q4 | -5 Million USD | -725.0% |
| 1992 Q2 | -600 Thousand USD | -160.0% |
| 1992 Q3 | 800 Thousand USD | 233.33% |
| 1991 Q4 | -4 Million USD | -463.64% |
| 1991 Q1 | - USD | 100.0% |
| 1991 Q2 | 1 Million USD | 0.0% |
| 1991 FY | - USD | 33.33% |
| 1991 Q3 | 1.1 Million USD | 10.0% |
| 1990 Q1 | 900 Thousand USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q3 | 1 Million USD | 0.0% |
| 1990 Q4 | -3.7 Million USD | -470.0% |
| 1990 Q2 | 1 Million USD | 11.11% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Achiko AG | -8.32 Million USD | 108.29% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | -2.84 Million USD | 124.248% |
| Cannabis Sativa, Inc. | -1.11 Million USD | 161.926% |
| CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 99.676% |
| Cogstate Limited | 9.89 Million USD | 93.022% |
| CareView Communications, Inc. | -210.04 Thousand USD | 428.598% |
| Craneware plc | 54.26 Million USD | 98.728% |
| Caduceus Software Systems Corp. | -12.29 Million USD | 105.615% |
| Certive Solutions Inc. | -704.66 Thousand USD | 197.946% |
| Drug Free Solution, Inc. | -1.39 Million USD | 149.479% |
| DATATRAK International, Inc. | 2.72 Million USD | 74.705% |
| Strainsforpains, Inc. | -65.61 Thousand USD | 1151.96% |
| Healixa Inc. | -6.32 Million USD | 110.92% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 10.16 Million USD | 93.213% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | 262.212% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | - USD | -Infinity% |
| IQ-AI Limited | -370.35 Thousand USD | 286.36% |
| Cannabiz Mobile, Inc. | -750.00 USD | 92125.467% |
| Mednow Inc. | -28.12 Million USD | 102.454% |
| Galileo Life Sciences, Inc. | -270.72 Thousand USD | 354.944% |
| MediXall Group, Inc. | -6.52 Million USD | 110.58% |
| Mitesco, Inc. | -11.96 Million USD | 105.769% |
| MobileSmith, Inc. | -13.83 Million USD | 104.988% |
| NantHealth, Inc. | -38.53 Million USD | 101.791% |
| Net Medical Xpress Solutions, Inc. | -1.69 Million USD | 140.647% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | -12.08 Million USD | 105.71% |
| Patient Access Solutions, Inc. | -12.09 Million USD | 105.705% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | 47.383% |
| PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | -823.58% |
| Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | 5764.732% |
| Renalytix Plc | -28.52 Million USD | 102.42% |
| Revium Recovery Inc. | -678 Thousand USD | 201.798% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | -369.00 USD | 187143.631% |
| Vaso Corporation | 4.19 Million USD | 83.547% |
| Vynleads, Inc. | -235.72 Thousand USD | 392.794% |